LncRNA HOXA-AS3 confers cisplatin resistance by interacting with HOXA3 in non-small-cell lung carcinoma cells

Many studies have indicated that the aberrant expression of long noncoding RNAs (lncRNAs) is responsible for drug resistance, which represents a substantial obstacle for cancer therapy. In the present study, we aimed to investigate the role of the lncRNA HOXA-AS3 in drug resistance and elucidate its...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shuang, Zhang, Rui, An, Xiaoxia, Li, Zhoubin, Fang, Cheng, Pan, Bo, Chen, Wei, Xu, Guodong, Han, Weili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794325/
https://www.ncbi.nlm.nih.gov/pubmed/31615976
http://dx.doi.org/10.1038/s41389-019-0170-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794325/
https://www.ncbi.nlm.nih.gov/pubmed/31615976
http://dx.doi.org/10.1038/s41389-019-0170-y

Ejemplares similares